Patent ID: 9144568
Filing Date: 2015-09-29
Classification: A61K,A61P

Abstract:
1. A method of treating chronic lymphocytic leukemia or indolent B cell non-Hodgkin's lymphoma comprising parenterally administering to a subject a volume of about 100 ml or less of a liquid composition comprising: a) from about 0.5 to about 5.6 mg/ml of bendamustine or a pharmaceutically acceptable salt thereof; b) a solubilizer comprising polyethylene glycol and propylene glycol, wherein the amount of solubilizer is from about 0.5 to about 26.5% vol; c) a parenterally acceptable diluent; and optionally d) an antioxidant; over a period of less than or equal to about 15 minutes to the subject.